Economic evaluation of kyphoplasty

Autor: M. Runge, Samuel Limat, J. Godard, A. Grumblat, M. Jehl-Rave, A. Voidey
Rok vydání: 2014
Předmět:
Zdroj: Le Pharmacien Hospitalier et Clinicien. 49:e197-e202
ISSN: 2211-1042
DOI: 10.1016/j.phclin.2014.06.001
Popis: Summary Objectives Without any refund of medical costs and with a high cost of products, an economic study has been conducted to compare the spendings and receipts of the hospital for a kyphoplasty. Methods The patients included in the survey were treated for kyphoplasty between January 2008 and December 2010. We took into account only direct medical costs: costs of products and hospitalization assessed by three methods [analytical accounting, French public Diagnosed-Related Group (DRG), and DRG adapted to the mean time of the hospitalization]. Results and discussion One hundred and two patients were enrolled in our study: 61% with vertebral compression fractures due to osteoporosis, 22% due to trauma, and 17% due to malignant disease. The patient stays are distributed in 17 DRG, with an average length of stay of 9.4 ± 10.0 days. For every hospitalization stay, the hospital gets 3740€ ± 2611. The average spendings are estimated at 9033€ by the analytical accounting, at 7679€ by DRG, and at 4548€ by DRG adapted to the mean time of the hospitalization. The average costs of products by procedure are 3930€, that is, 105% of the hospitals’ receipts. For each kyphoplasty, these receipts are not sufficient to balance the hospital's book.
Databáze: OpenAIRE